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S U M M A R Y
Optimizing antibiotic prescribing across the surgical pathway (before, during, and after surgery) is a key
aspect of tackling important drivers of antimicrobial resistance and simultaneously decreasing the
burden of infection at the global level. In the UK alone, 10 million patients undergo surgery every year,
which is equivalent to 60% of the annual hospital admissions having a surgical intervention. The
overwhelming majority of surgical procedures require effectively limited delivery of antibiotic
prophylaxis to prevent infections. Evidence from around the world indicates that antibiotics for surgical
prophylaxis are administered ineffectively, or are extended for an inappropriate duration of time
postoperatively. Ineffective antibiotic prophylaxis can contribute to the development of surgical site
infections (SSIs), which represent a signiﬁcant global burden of disease. The World Health Organization
estimates SSI rates of up to 50% in postoperative surgical patients (depending on the type of surgery),
with a particular problem in low- and middle-income countries, where SSIs are the most frequently
reported healthcare-associated infections. Across European hospitals, SSIs alone comprise 19.6% of all
healthcare-acquired infections. Much of the scientiﬁc research in infection management in surgery is
related to infection prevention and control in the operating room, surgical prophylaxis, and the
management of SSIs, with many studies focusing on infection within the 30-day postoperative period.
However it is important to note that SSIs represent only one of the many types of infection that can occur
postoperatively. This article provides an overview of the surgical pathway and considers infection
management and antibiotic prescribing at each step of the pathway. The aim was to identify the
implications for research and opportunities for system improvement.
© 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Introduction
Optimizing antibiotic prescribing across the surgical pathway
(before, during, and after surgery) is a key aspect of tackling
important drivers of antimicrobial resistance (AMR) and simulta-
neously decreasing the burden of infection at the global level. In
the UK alone, 10 million patients undergo surgery every year (The
Royal College of Anaesthetists, 2015), which is equivalent to 60% of
the annual hospital admissions having a surgical intervention
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(Anon, 2016). The overwhelming majority of surgical procedures
require effectively limited delivery of antibiotic prophylaxis to
prevent infections (Boucher et al., 2009; Bratzler et al., 2013).
Evidence from around the world indicates that antibiotics for
surgical prophylaxis are administered ineffectively, or are extend-
ed for an inappropriate duration of time postoperatively (Leeds
et al., 2016; Tan et al., 2006). Ineffective antibiotic prophylaxis can
contribute to the development of surgical site infections (SSIs),
which represent a signiﬁcant global burden of disease. The World
Health Organization (WHO) estimates SSI rates of up to 50% in
postoperative surgical patients (depending on the type of surgery),
with a particular problem in low- and middle-income countries
(LMICs), where SSIs are the most frequently reported healthcare-
associated infections (HCAIs) (Aveling et al., 2013; Aiken et al.,
2013; World Health Organization, 2016). Across European hospi-
tals, SSIs alone comprise 19.6% of all healthcare-acquired infections
(Anon, 2013). Much of the scientiﬁc research in infection
management in surgery is related to infection prevention and
control in the operating room (Birgand et al., 2014; Cosgrove, 2015;
Allo and Tedesco, 2005), surgical prophylaxis (Bratzler et al., 2013;
Cusini et al., 2010; Davey et al., 2013), and the management of SSIs
(Gaynes et al., 2001; Bergs et al., 2014), with many studies focusing
on infection within the 30-day postoperative period (World Health
Organization, 2016; Løwer et al., 2013). However it is important to
note that SSIs represent only one of the many types of infection
that can occur postoperatively.
This article provides an overview of the surgical pathway and
considers infection management and antibiotic prescribing at each
step of the pathway. The aim was to identify the implications for
research and opportunities for system improvement.
Infection management in surgery
To date, research on surgical antibiotic prescribing has focused
on the preoperative period and has largely been conﬁned to
prophylaxis, hospital inpatients, and SSIs. The WHO has recently
published guidelines for the prevention of SSIs (World Health
Organization, 2016). The guidelines provide detailed and evidence-
based recommendations for the prevention of SSIs, including
surgical antibiotic prophylaxis. The guidelines reinforce the
recommendation against prolongation of surgical antibiotic
prophylaxis beyond the surgical procedure as a means to prevent
SSIs. In addition, they recommend worldwide surveillance of SSIs
as a key component of any infection prevention and control
programme. However, they do reﬂect that SSI surveillance is
commonly poorly performed, with inconsistencies in practice,
including in the type, duration, and quality of the surveillance
(Table 1).
Beyond SSIs, there remains little research on the broader
management of postoperative HCAIs. In order to signiﬁcantly
mitigate against the drivers of AMR and simultaneously reduce
infection rates, it is critical to optimize antibiotic use before,
during, and after surgery, and to look at care settings beyond the
hospital  where most patients originate from and return to. Many
factors impact the risk of subsequent infection in a person who
undergoes surgery; the patient’s baseline health and wellbeing,
patient’s comorbidities, the healthcare professionals involved, and
how these professionals work as a team can all inﬂuence infection-
related surgical outcomes (Undre et al., 2006; Hull et al., 2011). The
management of the patient in the immediate postoperative period
is critical, as is their hospital length of stay. The risk of acquiring an
HCAI, e.g. hospital-acquired pneumonia (Garibaldi et al., 1981;
Conde and Lawrence, 2008), device-related bacteraemia, or
Clostridium difﬁcile-associated diarrhoea, is high in the surgical
patient (Krapohl et al., 2013) (Table 2). The use of invasive devices
such as intravenous lines, urinary catheters, and mechanical
ventilation increases the risk of postoperative infection. In addition
to this, the use of neuromuscular blocking agents during surgery to
aid anaesthesia, together with reduced mobility in the immediate
postoperative period, increases the risk of pneumonia (Bulka et al.,
2016; Sachdev and Napolitano, 2012), which carries an estimated
mortality of between 10% and 18%, even with appropriate
antibiotic treatment (Croce, 2000).
Antibiotic prescribing in surgery—culture and context
The surgical pathway has many actors, steps, and actions
speciﬁcally related to the management of infection and antibiotic
use. Nurses, surgeons, anaesthetists, pharmacists, and allied
healthcare professionals in the pre-assessment clinic, in the
operating room, on the ward, and in the community during
postoperative follow-up, all contribute to the care of the surgical
patient. Within this complex pathway, the responsibility for the
management of infection remains poorly deﬁned at each step. In
the operating room, it is unclear whether it is the anaesthetist or
the operating surgeon who should assume responsibility for the
timing, choice, and dose (or the need for a second dose) of the
prophylactic antibiotic (Grocott and Pearse, 2012; Parker et al.,
2000) (Table 1).
In the past few years, surgery has turned to aviation-inspired
checklists to improve the reliability of the processes of care, and
subsequently their outcomes. A number of checklists have been
published and evaluated in some detail, with the best known one
perhaps being the checklist developed by the WHO (Haynes et al.,
2009). These checklists have identiﬁed antibiotic prophylaxis to be
one of the objectives for safe surgery (World Health Organization,
2008). In the checklist, the requirement is that in the presence of
the nurse, anaesthetist, and surgeon, the ‘surgical team’ conﬁrm
that antibiotic prophylaxis, where appropriate, is administered
within 60 min of incision. However, the boundaries of responsibil-
ity for surgical antibiotic prophylaxis are not clear, speciﬁcally
whose responsibility it is to decide what antibiotic prophylaxis is
given and at what time (Tan et al., 2006). This is reported to be due
in part to the culture and hierarchies that inﬂuence the behaviour
of staff in the operating room, and also to the workﬂow and the
environment of the operating room, which can act as obstacles to
appropriate surgical antibiotic prophylaxis (Tan et al., 2006).
The lack of clarity around responsibility for antibiotic prescrib-
ing carries over into the postoperative period (Charani et al.,
2017a). The responsibility for antibiotic prescribing in surgical
teams is dispersed and the optimization of antibiotic therapy is
often not prioritized. This leads to inappropriate antibiotic use
with a prolonged duration (Leeds et al., 2016) (Table 1). This
prevalent culture surrounding antibiotic decision-making in
surgery needs to be understood and the expectation of surgical
teams in relation to stewardship should be adjusted in view of this
culture. Interventions in surgery should target the speciﬁc
behaviour determinants and they should be developed in closer
collaboration with surgical leaders.
Historically, most antibiotic stewardship programmes have
been focused on medical specialties (Davey et al., 2013; Davey
et al., 2017; Charani et al., 2017b). Within surgery, the ‘low hanging
fruit’ is surgical antibiotic prophylaxis, with the majority of
stewardship interventions targeting this single step (World Health
Organization, 2016; Davey et al., 2013). Enhanced recovery after
surgery (ERAS) programmes are now in place in many hospitals
worldwide, and a recent systematic review has demonstrated that
implementing such programmes can reduce HCAIs (Grant et al.,
2017).The ERAS protocols include recommendations for surgical
antibiotic prophylaxis, but focus more on the entire perioperative
plan for patients to promote rapid recovery and discharge
postoperatively (Lassen et al., 2009). Engagement with and
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inclusion of the surgical teams and surgical champions in the
development of antimicrobial stewardship programmes is the ﬁrst
step in bringing about better outcomes. Organizations and national
bodies can support this through legislation and policies that
promote and endorse better antibiotic prescribing across the
whole surgical pathway.
Although surgical checklists are generally shown to have
beneﬁcial effects in reducing surgical infections (Treadwell et al.,
Table 2
The incidence of the most commonly occurring healthcare-associated infections in postoperative patients.
Type of hospital-acquired infection Incidence range (as a percentage of postoperative patients) reported in the literaturea
Hospital-acquired pneumonia 2.5% (Conde and Lawrence, 2008) to 17.5% (Garibaldi et al., 1981)
Surgical site infections 1% to 9.8% (England PH, 2016)
Urinary tract infections 2% (Chan et al., 2013) to 10% (Stéphan et al., 2006)
Clostridium difﬁcile-associated diarrhoea 0.28% to 7.2% (Masgala et al., 2012; Flagg et al., 2014)
a Depends on the type of surgery and patient population; ﬁgures are from the published literature.
Table 1
Gaps in the surgical pathway and opportunities for system change that will impact infection management and antibiotic prescribing.
The surgical pathway
Perioperative period Postoperative period Follow-up care (primary/social/home) and
surveillance
Gaps in practice that
potentially impact
infection management
and antibiotic
prescribing
Lack of clarity on whose responsibility it is to
decide on the choice, dose, and timing of
antibiotic prophylaxis
Gaps in the diagnosis and management
of hospital-acquired infections in the
postoperative patient
Follow-up care:
Lack of clear understanding of the inﬂuence of
culture and team dynamics (Tschan et al., 2015)
on the implementation of the surgical
checklists, e.g., WHO checklist
Lack of leadership in antibiotic decision-
making
Community follow-up of care in the
postoperative period to ensure patient recovery
Operating room design issues, e.g.,
thoroughfare, airﬂow disruption, or poor
temperature control, or poorly designed
surfaces
Lack of knowledge on the inﬂuence of
culture and team dynamics on antibiotic
prescribing decisions in surgery
Surveillance:
LMIC-speciﬁc: lack of equipment to avoid
infection, lack of access to antibiotics
LMIC-speciﬁc: lack of access to
antibiotics
Lack of consistency in the method of SSI
surveillance, e.g.:
Duration of surveillance
Type of surveillance
Quality of surveillance
Feedback to surgical teams
Impact on clinical
processes and patient
outcomes
Inappropriate antibiotic prophylaxis resulting
in increased risk of SSIs
Inappropriate management of hospital-
acquired infections in the postoperative
patient, including prolonged duration of
antibiotic therapy
No system for linking SSI outcomes to antibiotic
prescribing behaviours before, during, and after
surgery
Ineffective environmental precautions to
prevent HCAIs
Lack of postoperative critical care
training leading to over-diagnosis of
sepsis in the postoperative period
Lack of adherence to SSI programmes
Opportunities for change Simple solutions such as: Provision of education and training at
post-graduate level
Developing a co-ordinated package of follow-up
care in the community
Clarity on roles and responsibilities for
antibiotic prophylaxis in the operating room
Provision of national and local
guidelines for antibiotic prescribing in
surgery
Building on existing surveillance and developing
new surveillance systems using a pragmatic
approach, e.g., National Surgical Quality
Improvement Programme (USA) or using mobile
phone-based surveillance (LMIC)
Monitoring operating room trafﬁc and airﬂow
to improve the operating room environment
and prevent infections
Inclusion of and engagement with
surgical teams in antibiotic stewardship
interventions
Organizational support and leadership in
implementing the changes
Developing better routes of access to
antibiotics
A greater understanding of the
inﬂuence of culture and context on
antibiotic prescribing behaviours
Development of context-speciﬁc
antimicrobial stewardship
interventions
Across the entire
pathway
Lack of engagement with, and involvement of, the surgical teams in antibiotic prescribing interventions, together with a lack of knowledge on
the optimization of antibiotic use in surgery (Charani et al., 2017a)
Opportunity for change: Deﬁning a role for antimicrobial stewardship within the surgical team, and developing targeted antibiotic
prescribing interventions in surgery
WHO, World Health Organization; LMIC, low- and middle-income countries; SSI, surgical site infection; HCAI, healthcare-associated infection.
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2014)  though not always SSIs (Haugen et al., 2015)  overall, they
have had a mixed reception (Aveling et al., 2013; Haynes et al.,
2009; Russ et al., 2015). In India, for example, despite improve-
ments in the use of the surgical site safety checklist, translation of
its use in terms of patient safety outcomes has not been measured
to understand the differences made in reducing SSIs, morbidity,
and mortality (Patel et al., 2015). Historically, LMICs have sub-
optimal investment in surgical services, and existing surgical
systems are growing too slowly to meet the increasing demand
(Ng-Kamstra et al., 2016). The success of interventions such as the
WHO checklist targeting surgical safety are highly context-
dependent and variable, and are inﬂuenced by economic, cultural,
and social factors, including role identity and hierarchies within
healthcare teams (Aveling et al., 2013). In particular, LMIC
hierarchies have a signiﬁcantly greater impact on the successful
adoption of interventions in surgery (Aveling et al., 2013).
Importantly, leadership, ﬂexibility, and teamwork are required
for the implementation of checklists to be effective in any setting
(Walker et al., 2012; Gillespie and Marshall, 2015). This lesson
applies to the successful implementation of any patient safety
initiative, including interventions aiming to optimize antibiotic use
(Undre et al., 2006; Dixon-Woods et al., 2013).
In particular for antibiotic prescribing, studies have described
the inﬂuence of cultural determinants on prescribing outcomes
(Charani et al., 2013). Antibiotic prescribing is a social act,
inﬂuenced by the perceived need for clinical autonomy of
individual prescribers and the existing hierarchies within teams
(Charani et al., 2013). Changing antibiotic prescribing behaviours,
with a view to optimizing patient-related infection outcomes,
cannot be done in isolation simply by providing guidelines and
policies. Existing guidelines and frameworks do not consider the
variance in resources and infrastructure within LMICs (World
Health Organization, 2016). In LMICs, inconsistencies in available
surgical capability and resources is far more pronounced between
rural and urban settings and between different LMIC countries,
than it is in high-income countries where the minimum standard
of care is provided in any setting. Research from different LMIC
settings is lacking and is urgently needed to develop contextually
sound and driven interventions that are sustainable.
The culture within specialties, organizations, and countries has
the power to inﬂuence the outcome of interventions (Hofstede,
2011; Buzan, 2010; Al-Bannay et al., 2013). Culture refers to how
individuals, as members of a team, learn and share knowledge in
order to generate behaviours (Spradley, 1980). Culture is learned,
and in order to inﬂuence practice, it needs to be studied. The
culture of treatment of infection and antibiotic use in the surgical
specialty has distinct features in contrast to acute medicine,
because the dynamic of decision-making in the patient surgical
pathway is different, as are the causal factors that inﬂuence
patient-related outcomes. Understanding the contextual and
cultural determinants of infection management and antibiotic
prescribing in surgery is critical to the development of context-
speciﬁc interventions that incorporate the need for ﬂexibility, local
leadership, and teamwork.
In an extensive review of the implementation of the Matching
Michigan intervention for the prevention of blood stream
infections by intensive care units in the UK (Dixon-Woods
et al., 2013), the researchers reported that local culture was
‘highly consequential’ to the intervention outcome. Furthermore,
the most successful units were reported to be those that had
adapted the intervention to the local context and used local
champions to drive and implement it. In surgery, one key step
would be better engagement with the surgical leaders and the
inclusion of surgeons in antimicrobial stewardship programmes.
With the increasing threat of AMR, there is an urgent need to
understand how to minimize the burden of infection and
optimize antibiotic use across the whole surgical pathway.
Addressing the gaps in the surgical pathway will reduce the
total antibiotic use and signiﬁcantly mitigate drivers for AMR and
the burden of infection (Table 1). Decision-making within
multidisciplinary surgical teams and communication with pro-
fessionals across organizational boundaries in LMICs remain
unexplored. Resource limitations mean that fewer actors are
involved in the surgical pathway, but there are also opportunities
for innovative team composition. In the global context it is
essential to redeﬁne the antibiotic stewardship roles of the entire
healthcare team across conventional organizational and profes-
sional boundaries. In addition, in LMICs the role of antibiotic
stewardship in surgical care pathways is imminent, since the
inappropriate use of antibiotic surgical prophylaxis has led to an
increase in SSIs (Rana et al., 2013). The need for research on this
topic in LMICs is particularly important to bring about efﬁciencies
at the organizational level and to address the huge impact on out-
of-pocket health expenditures and loss of earnings through
prolonged postoperative recovery for the most vulnerable in
society.
The way forward
Interventions in antibiotic use tend to consider and address
only one point at a time on the patient pathway, and in the case of
surgical patients, attention has been focused primarily on
prophylactic antibiotic use. And yet multiple interventions have
the potential to inﬂuence infection-related outcomes in the
surgical patient. Social science perspectives to understand the
structural, cultural contextual determinants of antibiotic use in
surgery need exploring, with the potential to inform sustainable
quality improvement and surgical safety initiatives. Identifying
and mapping current actors and actions in the surgical specialty in
different healthcare settings will inform interventions that are
context-speciﬁc and relevant to the local patient population. They
will also help ensure greater equity in access to safe surgery on a
global scale.
Addressing antibiotic prescribing and AMR across sectors and
cultures will enable surgical healthcare professionals to mobilize
and drive organizational, national, and global change. Engaging
with and involving surgeons and anaesthetists in the antibiotic
stewardship agenda is essential, especially as it will enable the
investigation of a critically unexplored domain in healthcare on a
global scale, and optimize interventions within and beyond
healthcare environments that have been entrenched in hierarchies
and cultural norms. Addressing the gap of infection management
in the surgical pathway will also impact on international policy and
practice in antibiotic resistance and stewardship. Addressing the
factors that inﬂuence AMR across the surgical pathway in
resource-limited environments has the potential to profoundly
impact the health outcomes of the millions of people who undergo
surgery each year.
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